Susan Hasty, Publisher
Table of Contents . . . May 13th, 2002
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in AIDS Weekly | Other Publications
AIDS and HIV Dementia - CD40-CD40L interactions may cause pathologic microglia activity
AIDS and HIV Pathogenesis - Other pathogens can inhibit HIV infection
AIDS and HIV Coinfection - Viral loads reduced during measles
AIDS and HIV Therapy - CCR5 is safe target for therapeutic agents
AIDS and HIV Therapy - Novel pyridinioalkanoyl thioesters show antiviral activity
AIDS-related Cancer - Tl-201 brain SPECT unsuitable for lymphoma diagnosis
Risk Factors - Many rural residents living with HIV continue risky behaviors
AIDS Complications - HIV in the nervous system - still a cause for concern?
AIDS Therapies - Trinity Medical Group USA announces study to broaden use of Remune
Appointments - Mark Leuchtenberger named president and CEO
Drug Approval - Pegasys-a, new hepatitis C treatment, clears important regulatory hurdle in Europe
Finance - Company reports 2001 financial results
Finance - ViroLogic raises $10 million through private placement
Nutrition - World Food Program plans food aid for Asian AIDS sufferers
Nutritional Supplements - Regent Group, Inc. receives HCPCS for Resurgex
Policy - AIDS 'dissidents' target health officials, other activists
Public Health Practice - Baltimore study supports targeting youth early to prevent bloodborne disease
Pulmonary Arterial Hypertension - Study highlights efficacy of Tracleer in life-threatening lung condition
RSV Infection - New U.S. patent covers oral respiratory syncytial virus drug
Stock Market - Viragen International to trade under new symbol
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.